1
Views
34
CrossRef citations to date
0
Altmetric
CLINICAL AND EXPERIMENTAL NEUROPSYCHOPHARMACOLOGY AND NEUROENDOCRINOLOGY

Magnetic Fields in the Therapy of Parkinsonism

Pages 209-235 | Received 04 Jun 1992, Published online: 23 Apr 2019

REFERENCES

  • Acuna-Castroviejo, D., Rosenstein, R. E., Romeo, H. E. & Cardinali, D. P. (1986). Changes in gamma-aminobutyric acid high affinity binding to cerebral cortex membranes after pinealectomy or melatonin administration to rats. Neuroendocrinology, 43, 24–31.
  • Agid, Y. & Javoy-Agid, F. (1985). Peptides and Parkinson's disease. Trends in Neurosciences, 5, 30–35.
  • Aldegunde, M., Miquez, I. & Veira, J. (1985). Effects of pinealectomy on regional brain serotonin metabolism. International Journal of Neuroscience, 26, 9–13.
  • Alvord, E. C. (1965). The pathology of parkinsonism: etiologic, pathogenetic and prognostic implications. Trans American Neurological Association, 90, 167–170.
  • Anderson, L. E. (1990). Interaction of electric and magnetic fields with neural and neuroendocrine systems. In B. W. Wilson, R. G. Stevens & L. E. Anderson (Eds.), Extremely low frequency electromagnetic fields: the question of cancer. Columbus, OH: Battelle Press.
  • Anninos, P. A., Tsagas, N., Sandyk, R. & Derpapas, K. (1991). Magnetic stimulation in the treatment of partial seizures. International Journal of Neuroscience, 60, 141–171.
  • Anton-Tay, F. (1974). Melatonin: effects on brain function. Advances in Biochemical Psychopharmacology, 11, 315–324.
  • Anton-Tay, F., Diaz, J. L. & Fernandez-Guardiola, A. (1971). On the effects of melatonin upon human brain. Its possible therapeutic implications. Life Sciences, 10, 841–850.
  • Astruc, J. (1971). Corticofugal connections of area 8 (frontal eye field) in Macaca mulatta. Brain Research, 33, 241–256.
  • Bar-Or, A. & Brown, G. M. (1989). Pineal involvement in the diurnal rhythm of nociception in the rat. Life Sciences, 44, 1067–1075.
  • Beckwith, B. E., Sandman, C. A., Hothersall, D. & Kastin, A. J. (1977). Influence of neonatal injections of alpha-MSH on learning, memory and attention in rats. Physiology & Behavior, 18, 63–71.
  • Bentin, S., Silverberg, R. & Gordon, H. W. (1981). Asymmetrical cognilive deterioration in demented and parkinsonian patients. Cortex, 17, 533–544.
  • Benton, A. (1985). Visuoperceptual, visuospatial, and visuoconstructive disorders. In K. M. Heilman & E. Valenstein (Eds.), Clinical neuropsychology, (pp. 151–186). New York: Oxford University Press.
  • Bernheimer, H., Birkmayer, W., Hornykiewicz, O., Jellinger, K. & Seitelberger, F. (1973). Brain dopamine and the syndromes of Parkinson and Huntington: clinical, morphological and neurochemical correlations. Journal of Neurological Sciences, 20, 415–455.
  • Bliss, V. L. & Heppner, F. H. (1976). Circadian activity rhythm influenced by near zero magnetic field. Nature, 261, 411–412.
  • Boller, F., Mizutani, T., Roessmann, U. & Gambetti, P. (1980). Parkinson disease, dementia, and Alzheimer's disease: clinicopathologic correlations. Annals of Neurology, 7, 329–335.
  • Boller, F., Passafiume, D., Rogers, K., Morrow, L. & Kim, Y. (1982). Visuospatial impairment in Parkinson's disease: role of perceptual and motor factors and of disease stage. Neurology, 32, 189.
  • Boller, F., Passafiume, D., Keefe, N. C. Rogers, K., Morrow, L. & Kim, Y. (1984). Visuospatial impairment in Parkinson's disease. Role of perceptual and motor factors. Archives of Neurology, 41, 485–490.
  • Bondareff, W., Mountjoy, C. Q. & Roth, M. (1982). Loss of neurons of origin of adrenergic projection to cerebral cortex (nucleus locus coeruleus) in senile dementia. Neurology, 32, 164–169.
  • Botez, M. I. Botez, T., Elie, R. & Attig, E. (1989). Role of the cerebellum in complex human behavior. Italian Journal of Neurological Sciences, 10, 291–30.
  • Bowen, F. P., Hoehn, M. M. & Yahr, M. D. (1972). Parkinsonism: alterations in spatial orientation as determined by a route-walking test. Neuropsychologia, 10, 355–361.
  • Bradbury, A. J., Kelly, M E. & Smith, J. A. (1985). Melatonin action in the mid-brain can regulate dopamine function both behaviourally and biochemically. In G. M. Brown & S. D. Wainwright (Eds.), The pineal gland: endocrine aspects (pp. 327–332). Oxford: Pergamon Press.
  • Brain, W. R. (1941). Visual disorientation with special reference to lesions of the right cerebral hemisphere. Brain, 64, 224–272.
  • Broughton, R. (1975). Biorhythmic variations in consciousness and psychological functions. Canadian Journal of Psychological Reviews, 16, 217–239.
  • Brown, R. G. & Marsden, C. D. (1984). How common is dementia in Parkinson's disease? Lancet, 1, 1262–1265.
  • Brown, R. G. & Marsden, C. D. (1986). Visuospatial function in Parkinson's disease. Brain, 109, 987–1002.
  • Brozoski, T. J., Brown, R. M., Rosvold, H. E. & Goldman, P. S. (1979). Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science, 205, 929–932.
  • Bubenik, G. A., Brown, G. M. & Grota, J. L. (1976). Differential localization of N-acetyled indoalkylamines in CNS and the Harderian gland using immunohistology. Brain Research, 118, 417–427.
  • Burton, S., Daya, S. & Potgieter, B. (1991). Melatonin modulates apomorphine-induced rotational behaviour. Experientia, 47, 466–469.
  • Cardinali, D. P., Vacas, M. I. & Estevez-Boyer, E. (1979). Specific binding for melatonin in bovine brain. Endocrinology, 105, 437–441.
  • Cash, R., Dennis, R. & L'Heureux, R., Raisman, R., Javoy-Agid, F. & Scatton, B. (1987). Parkinson's disease and dementia: norepineophrine and dopamine in locus ceruleus. Neurology, 37, 42–46.
  • Chang Chui, H. (1989). Dementia. A review emphasizing clinicopathologic correlation and brain-behavior relationships. Archives of Neurology, 46, 806–814.
  • Chics-DeMet, A., Chics-DeMet, E., Wu. H., Coopersmith, R. & Leon. M. (1988). Earth-strength magnetic fields selectively alter activity of the pineal gland and hippocampus. Neuroscience Abstracts, 156, 17.
  • Chouza, C., Romero, S., Laguardia, G. (1984). Hemi-parkinsonism: clinical, neuropsychological and tomographical studies. In R. G. Hassler & J. F. Christ (Eds.), Advances in neurology, (pp. 415–426). New York: Raven Press.
  • Clark, T. K. (1979). The locus ceruleus in behavior regulation: evidence for behavior specific vs general involvement. Behavioral Neural Biology, 25, 271–300.
  • Cooke, J. D., Brown, J. D. & Brecks, V. B. (1978). Increased dependence on visual information for movement control in patients with Parkinson's disease. Canadian Journal of Neurological Sciences, 5, 413–415.
  • Coslett, H. & Heilman, K. M. (1986). Male sexual function. Impairment after right hemisphere stroke. Archives of Neurology, 43, 1036–1039.
  • Cotzias, G. C., Tang. L. C., Miller, S. T. & Ginos, J. Z. (1971). Melatonin and abnormal movement induced by L-dopa mice. Science, 173, 450–452.
  • Creese, I., Burt, D. R. & Snyder, S. H. (1976). Dopamine receptor binding predicts clinical and pharmacological potencies of antipsychotic drugs. Science, 192, 481–483.
  • Critchley, M (1953). The parietal lobes. London: Edward Arnold Ltd.
  • Cummings, J. L. & Benson, D. F. (1984). Subcortical dementia. Review of an emerging concept. Archives of Neurology, 41, 874–879.
  • Daffner, K. R., Ahern. G. L., Weintraub, S. & Mesulam, M. M. (1990). Dissociated neglect behavior following sequential strokes in the right hemisphere. Annals of Neurology, 28, 97–101.
  • Damasio, A. R., Damasion, H. & Chang Chui, H. (1980). Neglect following damage to frontal lobe or basal ganglia. Neuropsychologia, 18, 123–132.
  • Danta, G. & Hilton, R. C. (1981). Judgment of visual vertical and horizontal in patients with parkinsonism. Neurology, 25, 43–47.
  • Datta, P. G. & King, M. (1979). Effects of MIF-1 and melatonin on novelty-induced defecation and associated plasma 11-OHC's and brain catecholamines. Pharmacology, Biochemistry and Behavior, 11, 173–181.
  • Datta, P. C. & King, M. G. (1980). Melatonin: effects on brain and behavior. Neuroscience & Behavioral Reviews, 4, 451–458.
  • Decety, J., Sjoholm, H., Ryding, E., Stenberg, G. & Ingvar, D. H. (1990). The cerebellum participates in mental activity: tomographic measurements of regional cerebral blood flow. Brain Research, 535, 313–317.
  • Demaine, C. & Semm, P. (1985). The avian pineal gland as an independent magnetic sensor. Neuroscience Letters, 62, 119–122.
  • Demaine, C. & Semm, P. (1986). Magnetic fields abolish nychthemeral rhythmicity of responses of Purkinje cells to the pineal hormone melatonin in the pigeon's cerebellum. Neuroscience Letters, 72, 158–162.
  • DeKosky, S., Heilman, K. M. & Bowers, D. (1980). Recognition and discrimination of emotional faces and pictures. Brain & Language, 9, 206–214.
  • DeRenzi, E., Faglioni, P. & Scotti, G. (1970). Hemispheric contribution to exploration of space through the visual and tactile modality. Cortex, 6, 191–203.
  • Dimond, S. J. (1976). Depletion of attentional capacity after total commissurotomy in man. Brain, 99, 347–356.
  • Direnfeld, L. K., Albert, L. M., Lolicer, L., Langlais, P. J., Marquis, I. & Kaplan, E. (1984). Parkinson's disease: the possible relationship of laterality to dementia and neurochemical findings. Archives of Neurology, 41, 935–941.
  • Dubocovich, M. L. (1983). Melatonin as a potent modulator of dopamine release in the retina. Nature, 306, 782–784.
  • Dugovic, C., Leysen, J. E. & Wauquier, A. (1989). Melatonin modulates the sensitivity of 5-hydroxytryptamine-2 receptor-mediated sleep-wakefulness regulation in the rat. Neuroscience Letters, 104, 320–325.
  • Dyster-Aas, K., Schally, A. V., deParra, M. L. V. & Velasco, M. (1971). Psychophysiologic correlates of MSH activity in man. Physiology & Behavior, 7, 893–896.
  • Ferrari, W. (1958). Behavioural changes in animals after intracisternal of MSH. Nature, 181, 925.
  • Flowers, K. (1978). Lack of prediction in the motor behavior of parkinsonism. Brain, 101, 35–52.
  • Freed, D. M. (1990). On the involvement of the locus ceruleus in Parkinson's disease. Journal of Neuropsychiatry and Clinical Neurosciences, 2, 114.
  • Freed, D. M., Corkin. S. & Growdon, J. (1988). Selective attention in Alzheimer's disease: CSF correlates of behavioral impairments. Neuropsychologia, 26, 895–902.
  • French, J. D. (1960). The reticular formation. In J. Fields, H. W. Magoun & V. E. Hall (Eds.), Handbook of physiology (pp. 1281–1306). Washington: American Physiological Society.
  • Fujimura, H. & Umbach, I. (1987). Role de l'atteinte de la substance reticulee dans la demence de la maladie de parkinson. Revieu Neurologique (Paris), 143, 108–114.
  • Gaffori, O. & Van Ree, J. M. (1985). Serotonin and antidepressant drugs antagonize melatonin-induced behavioural changes after injection into the nucleus accumbens of rats. Neuropharmacology, 24, 237–244.
  • Gaspar, P. & Gray, F. (1984). Dementia in idiopathic Parkinson's disease: a neuropathologic study of 32 cases. Acta Neuropathoogica (Berlin), 64, 43–52.
  • Gershanik, O., Heikkila, R. E. & Duvoisin, R. C. (1983). Behavioral correlations of dopamine receptor activation. Neurology, 33, 1489–1492.
  • Greenfield, J. G. & Bosanquet, F. D. (1953). The brainstem lesions in Parkinsonism. Journal of Neurology, Neurosurgery and Psychiatry, 16, 213–226.
  • Hakim, A. M. & Mathieson, G. (1979). Dementia in Parkinson's disease: a neuropathologic study. Neurology, 29, 1209–1214.
  • Halgin, R., Riklan, M. & Misiak, H. (1977). Levodopa, parkinsonism and recent memory. Journal of Nervous and Mental Disease, 164, 268–272.
  • Hansson, H. A. (1981). Purkinje nerve cell changes caused by electric fields: ultrastructural studies on long term effect on rabbits. Medical Biology, 59, 103–110.
  • Harik, S. I., LaManna, J. C., Snyder, S., Wetherbee, J. R. & Rosenthal, M., (1982). Abnormalities of cerebral oxidative metabolism in animal models of Parkinson's disease. Neurology, 32, 382–389.
  • Healton, E. B., Navarro, C., Bressman, S. & Brust, J. C. M. (1982). Subcortical neglect. Neurology, 32, 776–778.
  • Heilman, K. M. (1979). Neglect and related disorders. In K. M. Heilman & E. Valenstein (Eds.), Clinical neuropsychology (pp. 268–307). Oxford: Oxford University Press.
  • Heilman, K. M. & Valenstein. E. (1972). Frontal lobe neglect in man. Neurology, 22, 660–664.
  • Heilman, K. M. & Watson, R. T. (1979). Thalamic neglect. Neurology, 29, 690–694.
  • Heilman, K. M., Pandya, D. N. & Geschwind, N. (1970). Trimodal inattention following parietal lobe ablations. Trans American Neurological Association, 95, 259–261.
  • Heilman, K. M., Schwartz, H. & Watson, R. T. (1978). Hypoarousal in patients with neglect syndrome and emotional indifference. Neurology, 28, 229–232.
  • Heilman, K. M., Watson, R. T. & Valenstein, E. (1985). Neglect and related disorders. In K. M. Heilman & E. Valenstein (Eds.), Clinical neuropsychology (pp. 243–293). Oxford: Oxford University Press.
  • Henderson, V. W., Alexander, M. P. & Naeser, M. A. (1982). Right thalamic injury, impaired visuospatial perception, and alexia. Neurology, 32, 235–240.
  • Holmes, S. W. & Sugden, D. (1982). Effects of melatonin on sleep and neurochemistry in the rat. British Journal of Pharmacology, 76, 95–101.
  • Hornykiewicz, O. & Kish, S. J. (1990). Biochemical pathophysiology of Parkinson's disease. In M. D. Yahr & K. J. Bergmann (Eds.), Advances in neurology, vol. 45 (pp. 19–34). New York: Raven Press.
  • Hovestadt, A., De Jong, G. J. & Meerwaldt, J. D. (1988). Spatial disorientation in Parkinson's disease: no effect of levodopa substitution therapy. Neurology, 38, 1802–1803.
  • Hurst, J. H., LeWitt, P. A., Burns, R. S., Foster, N. L. & Lovenberg, W. (1985). CSF dopamine beta-hydroxylase activity in Parkinson's disease. Neurology, 35, 565–568.
  • Iversen, S. D. (1977). Striatal function and stereotyped behavior. In A. R. Cools, A. H. M. Lohman & J. H. L. Van den Bercken (Eds.), Psychobiology of the striatum (pp. 99–118). Amsterdam: North Holland Publishing Co.
  • Izumi, K., Donaldson, J., Minnich, J. & Barbeau, A. (1973). Quabain-induced seizures in rats: modification by melatonin and melanocyte-stimulating hormone. Canadian Journal of Physiology & Pharmacology, 51, 572–578.
  • Jaffe, R. A., Laszewski, B. L., Carr, D. B. & Phillips, R. D. (1980). Chronic exposure to a 60-Hz electric field: effects on synaptic transmission and peripheral nerve function in the rat. Bioelectromagnetics, 1, 131–137.
  • Javoy-Agid, F. & Agid, Y. (1980). Is the mesocortical dopaminergic system involved in Parkinson's disease? Neurology, 30, 1326–1330.
  • Jellinger, K. (1986). Pathology of Parkinsonism. In S. Fahn, C. D. Marsden, P. Jenner & P. Teychenne (Eds.), Recent developments in parkinson's disease (pp. 33–66). New York: Raven Press.
  • Jewesbury, E. C. O. (1969). Parietal lobe syndromes. In P. J. Vinken & G. W. Bruyn (Eds.), Handbook of clinical neurology: localization in clinical neurology vol. 2 (pp. 680–699). Amsterdam: North-Holland Publishing Company.
  • Joubert, M. & Barbeau, A. (1969). Akinesia in Parkinson's disease. In A. Barbeau & J. R. Brunette (Eds.), Progress in neurogenetics. Amsterdam: Exerpta Medica.
  • Jouvet, M. (1973). Essai sur le rêve. Archives of Italian Biology, 111, 564–576.
  • Kaplan, E. (1990). The process approach to neuropsychological assessment of psychiatric patients. Journal of Neuropsychiatry, 2, 72–87.
  • Karson, C. N., Berman, K. F., Kleinman, J. & Karoum, F. (1984). Seasonal variation in human central dopamine activity. Psychiatry Research, 11, 111–117.
  • Kastin, A. J. & Schally, A. V. (1967). Autoregulation of release of melanocyte stimulating hormone from the rat pituitary. Nature, March 25, 1238–1240.
  • Kastin, A. J., Redding, T. W. & Schally, A. V. (1967). MSH activity in rat pituitaries after pinealectomy. Proceedings of the Society of Experimental Biology and Medicine, 124, 1275–1277.
  • Kastin, A. J., Miller, L. H., Gonzalez-Barcena, D., Hawley, W. D., Dyster-Aas, K., Schally, A. V., deParra, M. L. V. & Velasco, M. (1971). Psychophysiologic correlates of MSH activity in man. Physiology & Behavior, 7, 893–896.
  • Kavaliers, M., Hirst, M. & Teskey, G. C. (1983). Aging, opioid analgesia and the pineal gland. Life Sciences, 32, 2279–2287.
  • Kebabian, J. W. & Calne, D. B. (1979). Multiple receptors for dopamine. Nature, 277, 93–96.
  • Kish, S. J., Shannak, K. S., Rajput, A. H., Gilbert, J. J. & Hornykiewicz, O. (1984). Cerebellar norepinephrine in patients with Parkinson's disease and control subjects. Archives of Neurology, 41, 612–614.
  • Kopp, N., Claustrat, B. & Tappaz, M. (1980). Evidence for the presence of melatonin in the human brain. Neuroscience Letters, 19, 231–242.
  • Kurlan, R. & Como, P. (1988). Drug-induced Alzheimerism. Archives of Neurology, 45, 356–357.
  • Laudon, M., Nir, I. & Zisapel, N. (1988). Melatonin receptors in discrete brain areas of the male rat. Impact of aging on density and on circadian rhythmicity. Neuroendocrinology, 48, 577–583.
  • Lees, A. J. & Smith, E. (1983). Cognitive deficits in the early stages of Parkinson's disease. Brain, 106, 257–270.
  • Lerchl, A., Nonaka, L. O., Stokkan, K. A. & Reiter, R. J. (1991). Marked rapid alterations in nocturnal pineal serotonin metabolism in mice and rats exposed to weak intermittent magnetic fields. Biochemistry, Biophysics Research Communication, 169, 102–108.
  • Leverenz, J. & Sumi, S. M. (1986). Parkinson's disease in patients with Alzheimer's disease. Archives of Neurology, 43, 662–664.
  • Lieberman, A. N. (1974). Parkinson's disease: a clinical review. American Journal of Medical Science, 267, 66–80.
  • Lieberman, H. R., Waldhauser, F., Garfield, G., Lynch, H. J. & Wurtman, R. J. (1984). Effects of melatonin on human mood and performance. Brain Research, 323, 201–207.
  • Lloyd, O. L. (1974). Inhibition of median raphe neurone metabolism by cerebrospinal fluid (CSF) containing 5-hydroxytryptamine and melatonin. Biochemical Pharmacology, 23, 1913–1915.
  • Mann, D. M. A. (1983). The locus coeruleus and its possible role in ageing and degenerative disease of the human central nervous system. Mechanisms of Ageing and Development, 23, 73–94.
  • Mann, D. M. A. & Yates, P. O. (1983). Pathological basis for neurotransmitter changes in Parkinson's disease. Neuropathology and Applied Neurobiology, 9, 3–19.
  • Mann, D. M. A., Yates, P. O. & Hawkes, J. (1982). Plaques, tangles and neurotransmitter deficiencies in dementia. Journal of Neurology Neurosurgery and Psychiatry, 45, 563–564.
  • Mann, D. M. A. Yates, P. O. & Hawkes, J. (1983). The pathology of the human locus coeruleus. Clinical Neuropathology, 2, 1–7.
  • Marczynski, T. J., Yamaguchi, N., Ling, G. M. & Grodzinska, L. (1964). Sleep induced by the administration of melatonin (5-methoxy-N-acetyltryptamine) to the hypothalamus in unrestrained cats. Experientia, 20, 435–437.
  • Marshall, J. F., Turner, B. H. & Teitelbaum, P. (1971). Sensory neglect produced by lateral hypothalamic damage. Science, 174, 523–525.
  • Mason, S. T. & Ivesen, S. D. (1978). Reward, attention and the dorsal noradrenergic bundle. Brain Research, 150, 135–148.
  • Matthews, C. G. & Haaland, Y. (1979). The effect of symptom duration on cognitive and motor performance in parkinsonism. Neurology, 29, 951–956.
  • Mayeux, R. (1987). Mental state. In W. C. Koller (Ed.), Handbook of Parkinson's disease (pp. 127–144). New York: Marcel Dekker.
  • Mayeux, R., Stern, Y. & Rosen, J. (1980). Visuospatial function in Parkinson's disease. Neurology, 30, 392.
  • Mayeux, R., Stern, Y., Rosen, J. & Leventhal, J. (1981). Depression, intellectual impairment and Parkinson's disease. Neurology, 31, 645–650.
  • Mayeux, R., Stern, Y., Sano, M., Cote, L. & Williams, J. B. W. (1987). Clinical and biochemical correlates of bradyphrenia in Parkinson's disease. Neurology, 37, 1130–1134.
  • McFie, J., Piercy, M. F. & Zangwill, O. L. (1950). Visual spatial agnosia associated with lesions of the right cerebral hemisphere. Brain, 73, 167–190.
  • Mehler, W. R. (1966). Further notes on the central median nucleus of Luys. In D. P. Purpura & M. D. Yahr (Eds.), The thalamus (pp. 109–127). New York: Columbia University Press.
  • Meier, M. J. & Story, J. L. (1976). Selective impairment of Proteus Maze test performance after right subthalamotomy. Neuropsychologia, 5, 181–189.
  • Melamed, E., Rosenthal, J., Uzzan, A. & Brzewzinski, A. (1986). Effect of systemic melatonin administration on dopamine turnover in mouse retina. Journal of Neural Transmission, 21 (suppl), 499–500.
  • Mesulam, M. M. (1981). A cortical network for directed attention and unilateral neglect. Annals of Neurology, 10, 304–325.
  • Mesulam, M. M., Waxman, S. G., Geschwind, N. & Sabin, T. D. (1976). Acute confusional states with right middle cerebral artery infarctions. Journal of Neurology, Neurosurgery and Psychiatry, 39, 84–89.
  • Michaelson, S. M. & Lu, S. T. (1992). Factors in postmeridial hormone changes among rats in electric field exposure studies. In M. C. Moore-Ede, S. S. Campbell & R. J. Reiter (Eds.), Electromagnetic fields and circadian rhythmicity (pp. 77–94). Boston: Birkhauser.
  • Miyata, S., Nagata, H., Yamao, S., Nakamura, S. & Kameyama, M. (1984). Dopamine beta-hydroxylase activities in serum and cerebrospinal fluid of aged and demented patients. Journal of the Neurological Sciences, 63, 403–409.
  • Mohr. E., Juncos, J., Cox, C., Litvan, I., Fedio, P. & Chase, T. N. (1990). Selective deficits in cognition and memory in high-functioning Parkinsonian patients. Journal of Neurology, Neurosurgery and Psychiatry, 53, 603–606.
  • Moore-Ede, M. C., Campbell, S. S. & Reiter, R. J. (1992). Introduction. In M. C. Moore-Ede, S. S. Campbell & R. J. Reiter (Eds.), Electromagnetic fields and circadian rhythmicity (pp. 3–10). Boston: Birkhausen
  • Mortimer, J. A., Pirozzolo, F. J. & Hansch. E. C. (1982). Relationship of motor symptoms to intellectual deficits in Parkinson's disease. Neurology, 32, 133–137.
  • Nauta, H. J. W. (1986). The relationship of the basal ganglia to the limbic system. In P. J. Vinken, G. W. Bruyn & H. L. Klawans (Eds.), Handbook of clinical neurology: extrapyramidal disorders, vol. 5, (pp. 19–31). North Holland: Elsevier Science Publishers.
  • Neary, D., Snowden, J. S. & Bowen, D. M. (1986). Neuropsychological syndromes in presenile dementia due to certebral atrophy. Journal of Neurology Neurosurgery and Psychiatry, 49, 163–174.
  • Niles, L. P., Brown, G. M. & Mishra, R. K. (1983). Effects of blinding and pinealectomy on regional brain monoamine concentrations. Journal of Neuroscience Research, 10, 53–60.
  • Niles, L. P., Wong, Y. W., Mishra, R. K. & Brown, G. M. (1973). Melatonin receptors in brain. European Journal of Pharmacology, 55, 219–220.
  • Nowak, J. Z. (1988). Melatonin inhibits (3H) dopamine release from rabbit retina evoked by light, potassium, and electrical stimulation. Medical Science Research, 16, 1073–1075.
  • Olcese, J. (1992). Magnetoreception in rodents: involvement of the eyes and the pineal organ may be evidence for a chronobiological substrate. In M. C. Moore-Ede, S. S. Campbell & R. J. Reiter (Eds.), Electromagnetic fields and circadian rhythmicity (pp. 63–73). Boston: Birkhauser.
  • Olcese, J., Reuss, S. & Vollrath, L. (1985). Evidence for the involvement of the visual system in mediating magnetic field effect on pineal melatonin synthesis in the rat. Brain Research, 333, 382–384.
  • Olcese, J., Reuss, S. & Semm, P. (1988). Geomagnetic field detection in rodents. Life Sciences, 42, 605–613.
  • Ossenkopp, K. P., Kavaliers, M. & Hirst, M. (1983). Reduced nocturnal morphine analgesia in mice following a geomagnetic disturbance. Neuroscience Letters, 40, 321–325.
  • Paterson, A. T., Rickerby, J., Simpson, J. & Vickers, J. (1980). Possible interaction of melanocyte stimulating hormone (MSH) and the pineal in the control of territorial aggression in mice. Physiology & Behavior, 24, 843–848.
  • Pazo, J. H. (1979). Effects of melatonin on spontaneous and evoked neuronal activity in the mesencephalic reticular formation. Brain Research Bulletin, 4, 725–730.
  • Perry, R. H. Tomlinson, B. E. & Candy, J. M. (1983). Cortical cholinergic deficit in mentally impaired parkinsonian patients. Lancet, 2, 789–790.
  • Pillon, B., Dubois, B., Bonnet. A. M., Esteguy, M., Guimaraes, J., Vigouret, J. M., L'hermitte, F. & Agid, Y. (1989). Cognitive slowing in Parkinson's disease fails to respond to levodopa treatment: the 15-objects test. Neurology, 39, 762–768.
  • Pirozzolo, F. J., Hansch, E. C. & Mortimer, J. A. (1982). Dementia in Parkinson's disease: A neuropsychological analysis. Brain and Cognition, 1, 71–83.
  • Proctor, F., Riklan, M., Cooper, I. S. & Teuber, H. L. (1964). Judgement of visual vertical and postural vertical by parkinsonian patients. Neurology, 14, 287–293.
  • Quabain-induced seizures in rats: modification by melatonin and melanocyte-stimulating hormone. Canadian Journal of Physiology & Pharmacology, 51, 572–578.
  • Quinn, N., Rossor, M. N. & Marsden, C. D. (1986). Dementia and Parkinson's disease: pathological and neurochemical considerations. British Medical Bulletin, 42, 86–90.
  • Raskin, S. A., Borod, J. C., Wasserstein, J., Bodis-Wollner, I., Coscia, L. & Yahr, M. D. (1990). Visuospatial orientation in Parkinson's disease. International Journal of Neuroscience, 51, 9–18.
  • Reiter, R. J. (1992). Changes in circadian melatonin synthesis in the pineal gland of animals exposed to extremely low frequency electromagnetic radiation: A summary of observations and speculation on their implications. In . In M. C. Moore-Ede, S. S. Campbell & R. J. Reiter (Eds.), Electromagnetic fields and circadian rhythmicity (pp. 13–27). Boston: Birkhauser.
  • Reuss, S., Semm, P. & Vollrath, L. (1983). Different types of magnetically sensitive cells in the rat pineal gland. Neuroscience Letters, 40, 23–26.
  • Reynolds, G. P. & Riederer, P. (1990). The neuropharmacology of Parkinson's disease. In G. Stern (Ed.), Parkinson's disease (pp. 127–149). London: Chapman and Hall Medical.
  • Richardson, B. A., Yaga, K., Reiter, R. J. & Hoover, P. (in press). Suppression of nocturnal pineal N-acetyltransferase activity and melatonin content by inverted magnetic fields and induced eddy currents. International Journal of Neuroscience.
  • Riklan, M. & Levita, E. (1969). Subcortical correlates of human behavior. Baltimore: Williams and Wilkins.
  • Robbins, T. W. (1984). Cortical noradrenaline, attention and arousal. Psychological Medicine, 14, 13–21.
  • Rosenstein, R. E. & Cardinali, D. P. (1986). Melatonin increases in vivo GABA accumulation in rat hypothalamus, cerebellum, cerebral cortex and pineal gland. Brain Research, 398, 403–406.
  • Sallanon, M., Claustrat, B. & Touret, M. (1982). Presence of melatonin in various cat brainstem nuclei determined by radioimmunoassay. Acta Endocrinologica, 101, 161–165.
  • Sandman, C. A., George, J. M., Nolan, J. D., Riezen, H. Y. & Kastin, A. J. (1974). Enhancement of attention in man with ACTH/MSH 4-10. Physiology & Behavior, 15, 427–431.
  • Sandman, C. A., George, J., Walker, B. B., Nolan, J. D. & Kastin, A. J. (1976). Neuropeptide MSH/ACTH 4-10 enhances attention in the mentally retarded. Pharmacology, Biochemistry, and Behavior, 5 (suppl 1). 23–28.
  • Sandman, C. A., George, J., McCanne, T. R., Nolan, J. D., Kaswan, J. & Kastin, A. J. (1977). MSH/ACTH 4-10 influences behavioral and physiological measures of attention. Journal of Clinical Endocrionology & Metabolism, 44, 884–891.
  • Sandyk, R. (1988). Tardive dyskinesia and the pineal gland. International Journal of Neuroscience, 43, 11 1–114.
  • Sandyk, R. (in press a). Weak magnetic fields as a novel therapeutic modality in Parkinson's disease. International Journal of Neuroscience.
  • Sandyk, R. (in press b). Weak magnetic fields in the treatment of Parkinson's disease with the “on-off” phenomenon. International Journal of Neuroscience.
  • Sandyk, R. & Iacono, R. P. (1988). The relationship of the reticular system to the primary pathoetiology of Parkinson's disease. International Journal of Neuroscience, 42, 297–300.
  • Sandyk, R. & Fisher, H. (1989). Increased incidence neurolcptic-induced movement disorders in pinealectomized rats. International Journal of Neuroscience, 48, 303–308.
  • Sandyk, R. & Kay, S. R. (1990). Melatonin secretion and the pathophysiology of Meige's disease (idiopathic orofacial dystonia). A hypothesis. Functional Neurology, 5, 165–170.
  • Sandyk, R. & Anninos, P. A. (in press). Attenuation of epilepsy with application of external magnetic fields: A case report. International Journal of Neuroscience.
  • Sandyk, R., Awerbuch, G. & Kay, S. R. (1990). Pineal gland calcification and tardive dyskinesia. Lancet, 335, 1528.
  • Sandyk, R., Anninos, P. A. & Tsagas, N. (1991). Magnetic fields and the habenular complex. International Journal of Neuroscience, 59, 263–266.
  • Sandyk, R., Anninos, P. A., Tsagas, N. & Derpapas, K. (1992). Magnetic fields in the treatment of Parkinson's disease. International Journal of Neuroscience, 63, 141–150.
  • Scatton, B., Javoy-Agid, F., Rouquier L., Dubois, B. & Agid, Y. (1983). Reduction of cortical dopamine. noradrenaline, serotonin and their metabolites in Parkinson's disease. Brain Research, 275, 321–328.
  • Schachter, M., Bedard, P., Debono, A. G., Jenner, P., Marsden, C. D., Rosenthaler, J., Horowski, R. & Dorow, R. (1981). The role of D-1 and D-2 receptors. Nature, 286, 157–159.
  • Seeman, P., Lee, T., Chau-Wong, M. & Wong, K. (1976). Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature, 261, 717–719.
  • Seguela, P., Geffard, M., Chauveau, J., Muyard, J. P., Biziere, K. & Le Moal, M. (1982). Selective increase of melatonin content in pineal gland and nucleus accumbens after peripheral injection of Des-Tyr1-gamma-endorphin in the rat. Neuroscience Letters, 10, S442.
  • Semm, P. (1983). Neurobiological investigations on the magnetic sensitivity of the pineal gland in rodents and pigeons. Comparative Biochemistry and Physiology, 76A, 683–689.
  • Semm, P. (1992). Pineal function in mammals and birds is altered by earth-strength magnetic fields. In M. C. Moore-Ede, S. S. Campbell & R. J. Reiter (Eds.), Electromagnetic fields and circadian rhythmicity (pp. 53–62). Boston: Birkhauser.
  • Semm, P. & Vollrath, L. (1984). Electrical responses of homing pigeon and guinea pig Purkinje cells to pineal indoleamines applied by microelectrophoresis. Journal of Comparative Physiology, 154, 675–681.
  • Semm, P., Schneider, T. & Vollrath, L. (1980). Effects of an earth-strength magnetic field on electrical activity of pineal cells. Nature, 288, 607–608.
  • Sharpe, M. H., Cermak, S. A. & Sax, D. S. (1983). Motor planning in Parkinsonian patients. Neuropsychologia, 21, 455–462.
  • Stankov, B., Fraschini, F. & Reiter, R. J. (1991). Melatonin binding sites in the central nervous system. Brain Research Reviews, 16, 245–256.
  • Starkstein, S., Leiguarda, R., Gershanik, O. & Berthier, M. (1987). Neuropsychological disturbances in hemiparkinson's disease. Neurology, 37, 1762–1764.
  • Stein, L., Belluzi, J. D. & Wise, C. D. (1975). Memory enhancement by central administration of norepinephrine. Brain Research, 84, 329–335.
  • Stern, Y. & Langston, J. W. (1985). Intellectual changes in patients with MPTP-induced parkinsonism. Annals of Neurology, 35, 1506–1509.
  • Stern, Y., Mayeux, R. & Rosen, J. (1984). Contribution of perceptual motor dysfunction to construction and tracing disturbances in Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry, 47, 983–989.
  • Stern, Y., Mayeux, R., Rosen, J. & Ilson, J. (1983). Perceptual motor dysfunction in Parkinson's disease: a deficit in sequential and predictive voluntary movement. Journal of Neurology, Neurosurgery and Psychiatry, 46, 145–151.
  • Stutz, A. M. (1971). Effects of weak magnetic fields on gerbil spontaneous activity. Annals New York Academy of Sciences, 187, 312–323.
  • Sudarsky, L., Morris, J. & Romero, J. (1989). Dementia in Parkinson's disease: the problem of clinicopathologic correlation. Journal of Neuropsychiatry and Clinical Neurosciences, 1, 159–166.
  • Sugden, D. & Morris, R. D. (1979). Changes in regional brain levels of tryptophan. 5-hydroxytryptamine, 5-hydroxyindoleaceticacid, dopamine and noradrenaline after pinealectomy. Journal of Neurochemistry, 32, 1593–1594.
  • Teuber, H. L. (1976). Complex function of basal ganglia. In M. D. Yahr (Ed.), The basal ganglia (pp. 151–168). New York: Raven Press.
  • Teuber, H. L. & Proctor, F. I. (1964). Some effects of basal ganglia lesions in subhuman primates and man. Neuropsychoogia, 2, 83–93.
  • Ungerstedt, U. (1973). Selective lesions of central catecholamine pathways: application in functional studies. In S. Ehrenpreis & I. Kopin (Eds.), Neuroscience research vol. 5 (pp. 73–96). New York: Academic press.
  • Vacas, M. I. & Cardinali, D. P. (1979). Diurnal changes in melatonin binding sites of hamster and rat brains. Correlation with neuroendocrine responsiveness to melatonin. Neuroscience Letters, 15, 259–263.
  • Van Dongen, P. A. M. (1981). The human locus coeruleus in neurology and psychiatry. Progress in Neurobiology, 17, 97–139.
  • Veith, J. L., Sandman, C. A., George, J. M. & Stevens, V. C. (1978). Effects of MSH/ACTH 4-10 on memory, attention and endogenous hormone levels in women. Physiology & Behavior, 20, 43–50.
  • Villardita, C., Smirni, P. & Le Pira, F. (1982). Mental deterioration, visuoperceptive disabilities and constructional apraxia in Parkinson's disease. Acta Neurologica Scandinavica, 66, 112–120.
  • Villardita, C., Smirni, P. & Zappala, G. (1983). Visual neglect in Parkinson's disease. Archives of Neurology, 40, 737–739.
  • Vitte, P. A., Harthe, C., Lestage, P., Claustrat, B. & Bobillier, P. (1988). Plasma, CSF and brain distribution of 14C-melatonin in rat: a biochemical and autoradiographic study. Journal of Pineal Research, 5, 437–453.
  • Vitte, P. A., Harthe, C., Pevet, P. & Claustrat, B. (1990). Brain autoradiographic study in the golden hamster after intracarotid injection of [14C] melatonin. Neuroscience Letters, 110, 1–5.
  • Watson, P. J. (1978). Non-motor functions of the cerebellum. Psychological Bulletin, 85, 944–967.
  • Watson, M. & McElligot, J. G. (1982). Diminished improvement in acquisition of a specific locomotor task after localized 6-hydroxydopamine induced cerebellar norepinephrine depletion. Neuroscience Abstracts, 8, 392.
  • Watson, R. T., Heilman, K. M. & Cauthen, J. C. (1973). Neglect after cingulolectomy. Neurology, 23, 1003–1007.
  • Watson, R. T., Heilman, K. M. & Miller, B. D. (1984). Neglect after mesecephalic reticular formation lesions. Neurology, 24, 294–298.
  • Welker, H. A., Semm, P., Willig, R. P., Commentz, J. C., Wiltschko, W. & Vollrath, L. (1983). Effects of an artificial magnetic field on serotonin N-acetyltransferase activity and melatonin content of the rat pineal gland. Experimental Brain Research, 50, 426–432.
  • Wever, R. (1968). Einfluss Schwacher Elektro-magnetischer Felder auf die Circadiane Periodik des Menschen. Naturwissenschaften, 55, 29–32.
  • Wever, R. (1992). Circadian rhythmicity of man under the influence of weak electromagnetic fields. In M. C. Moore-Ede, S. S. Campbell & R. J. Reiter (Eds.), Electromagnetic fields and circadian rhythmicity (pp. 121–139). Boston: Birkhauser.
  • Whitehouse, P. J., Hedreen, J. C., While, C. L. & Price, D. L. (1983). Basal forebrain neurons in the dementia of Parkinson disease. Annals of Neurology, 13, 243–248.
  • Williams, L. M., Morgan, P. J., Hatings, M. H., Lawson, W., Davidson, G. & Howell, H. E. (1989). Melatonin receptors sites in the Syrian hamster brain and pituitary. Localization and characterization using [125|]iodomelatonin. Journal of Neuroendocrinology, 1, 315–320.
  • Wilson, B. W., Chess, E. K. & Anderson, L. E. (1986). 60-Hz electric field effects on pineal melatonin rhythms. Bioelectromagnetics, 7, 239–242.
  • Wilson, B. W., Stevens, R. G. & Anderson, L. E. (1992). Effects of electromagnetic field exposure on neuroendocrine function. In M. C. Moore-Ede, S. S. Campbell & R. J. Reiter (Eds.), Electromagnetic fields and circadian rhythmicity (pp. 29–50). Boston: Birkhauser.
  • Wolf-Klein, G. P., Silverstone, F. A., Levy, A. P. & Brod, M. S. (1989). Screening for Alzheimer's disease by clock drawing. Journal of the American Geriatrics Society, 37, 730–734.
  • Zisapel, N. & Laudon, M. (1983). Inhibition by melatonin of dopamine release from rat hypothalamus: regulation of calcium entry. Brain research, 272, 378–381.
  • Zisapel, N., Egozi. Y. & Laudon, M. (1982). Inhibition of dopamine release by melatonin: regional distribution in the rat brain. Brain Research, 246, 161–163.
  • Zisapel, N., Egozi, Y. & Laudon, M. (1983). Inhibition by melatonin of dopamine release from rat hypothalamus in vitro: variations with sex and the estrous cycle. Neuroendocrinology, 37, 41–47.
  • Zisapel, N., Egozi, Y. & Laudon, M. (1985). Circadian variations in the inhibition of dopamine release from adult and newborn rat hypothalamus by melatonin. Neuroendocrinology, 40, 102–108.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.